Lindy Durrant, Scancell CEO
Giving first glimpse of data, Scancell looks for Covid-19 vaccine partner
UK-based biotech Scancell is lifting the veil off a Phase I trial for its Covid-19 vaccine, but it’ll also be making a pivot on the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
